Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Hogan

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Oncotarget|November 14, 2014
Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cellsYosuke Harazono, Dhong Hyo Kho, Vitaly Balan, et al.
International Journal of Cancer|February 18, 2010
Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancerPratima Nangia-Makker, Yi Wang, Tirza Raz, et al.
Cancer Metastasis Reviews|April 13, 2016
Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis managementKosei Nakajima, Dong Hyo Kho, Takashi Yanagawa, et al.
Neoplasia (New York, N.Y.)|November 27, 2014
Galectin-3 inhibits osteoblast differentiation through notch signalingKosei Nakajima, Dhong Hyo Kho, Takashi Yanagawa, et al.
Journal of the National Cancer Institute|December 19, 2002
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectinPratima Nangia-Makker, Victor Hogan, Yuichiro Honjo, et al.
Cancer Research|December 19, 2012
Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cellsDhong Hyo Kho, Pratima Nangia-Makker, Vitaly Balan, et al.
The American Journal of Pathology|March 17, 2009
Regulation of prostate cancer progression by galectin-3Yi Wang, Pratima Nangia-Makker, Larry Tait, et al.
Cancer Research|September 6, 2005
Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cellsNatsuo Oka, Susumu Nakahara, Yukinori Takenaka, et al.
FEBS Letters|January 16, 2003
The enzymatic activity of phosphoglucose isomerase is not required for its cytokine functionSoichi Tsutsumi, Suresh K Gupta, Victor Hogan, et al.
Cancer Research|December 18, 2003
CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosisTomoharu Fukumori, Yukinori Takenaka, Tadashi Yoshii, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Oncotarget|November 14, 2014
Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cellsYosuke Harazono, Dhong Hyo Kho, Vitaly Balan, et al.
International Journal of Cancer|February 18, 2010
Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancerPratima Nangia-Makker, Yi Wang, Tirza Raz, et al.
Cancer Metastasis Reviews|April 13, 2016
Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis managementKosei Nakajima, Dong Hyo Kho, Takashi Yanagawa, et al.
Neoplasia (New York, N.Y.)|November 27, 2014
Galectin-3 inhibits osteoblast differentiation through notch signalingKosei Nakajima, Dhong Hyo Kho, Takashi Yanagawa, et al.
Journal of the National Cancer Institute|December 19, 2002
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectinPratima Nangia-Makker, Victor Hogan, Yuichiro Honjo, et al.
Cancer Research|December 19, 2012
Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cellsDhong Hyo Kho, Pratima Nangia-Makker, Vitaly Balan, et al.
The American Journal of Pathology|March 17, 2009
Regulation of prostate cancer progression by galectin-3Yi Wang, Pratima Nangia-Makker, Larry Tait, et al.
Cancer Research|September 6, 2005
Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cellsNatsuo Oka, Susumu Nakahara, Yukinori Takenaka, et al.
FEBS Letters|January 16, 2003
The enzymatic activity of phosphoglucose isomerase is not required for its cytokine functionSoichi Tsutsumi, Suresh K Gupta, Victor Hogan, et al.
Cancer Research|December 18, 2003
CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosisTomoharu Fukumori, Yukinori Takenaka, Tadashi Yoshii, et al.
Pageof 4